Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology

Understanding Your Child's Scans, Labs, and Tests

At a Glance

Cobblestone lissencephaly is diagnosed and monitored through MRIs showing a bumpy brain surface, CK blood tests to check for muscle damage, eye exams for vision issues, and genetic testing. Understanding these results helps caregivers build a precise care plan with their medical team.

When you receive a stack of medical reports, the language can feel cold and intimidating. However, these documents are like a map of your child’s unique biology. Learning to “read the map” can help you ask the right questions and ensure your child receives the most precise care possible.

Decoding the MRI: The Brain’s Structure

Magnetic Resonance Imaging (MRI) is the primary tool doctors use to see the “cobblestone” pattern. Here are the key terms you might see on a report:

  • Cobblestone Cortex: Instead of the typical smooth curves (gyri) of the brain, the surface looks pebbled or irregular. This is caused by neurons traveling past their “stop sign” and into the space around the brain [1][2].
  • Z-Shaped Brainstem: The brainstem is the “trunk” of the brain that controls basic life functions. In cobblestone lissencephaly, the brainstem may look “kinked” or folded into a Z-shape [3][4].
  • Cerebellar Cysts and Hypoplasia: The cerebellum (the part of the brain at the back that controls balance) may be smaller than usual (hypoplasia) or contain small, fluid-filled sacs called cysts [5][6].
  • Ventriculomegaly or Hydrocephalus: This refers to the fluid-filled spaces in the brain being larger than normal. If the fluid is under pressure, it is called hydrocephalus, which may require a small tube (shunt) to drain the excess fluid [7][8].

The Lab Results: Measuring Muscle Health

Because this condition often affects the muscles, doctors use a blood test called a Creatine Kinase (CK) test [9].

  • What is CK? Creatine kinase is an enzyme found inside healthy muscle cells. When muscle cells are fragile or damaged—as they are in congenital muscular dystrophies—this enzyme leaks out into the bloodstream [9].
  • What do the numbers mean? A high CK level (often 2 to 50 times higher than normal) is a “bio-marker” that tells doctors the muscles are under stress [10][11]. It helps confirm that the brain findings are part of a broader alpha-dystroglycanopathy [9][12].

The Eye Exam: Screening for Vision

The same genetic “Velcro” that holds the brain and muscles together is also vital for the eyes. A pediatric ophthalmologist will look for:

  • Retinal Dysplasia: The retina (the “film” at the back of the eye) may be malformed or detached [13][8].
  • Cataracts or Glaucoma: Clouding of the lens (cataracts) or high pressure in the eye (glaucoma) can occur and may require treatment to protect the child’s remaining vision [14].

Genetic Testing: Finding the “Why”

To get a definitive diagnosis, doctors usually recommend Whole Exome Sequencing (WES) or a targeted gene panel [15][16].

  • Gene Panels: These look specifically at a pre-set list of genes known to cause muscular dystrophy and brain malformations [17].
  • WES: This is a broader search that looks at almost all of a child’s genes. It is often used to find rare or “novel” mutations that a standard panel might miss [18][19].

Care Team Checklist

Ensure your team has addressed the following baseline evaluations:

  1. Baseline MRI: Has a neurologist reviewed the specific shape of the brainstem and cerebellum? [5]
  2. Blood Work: Has a CK level been taken to assess muscle involvement? [9]
  3. Specialized Eye Exam: Has your child seen a pediatric ophthalmologist? [13]
  4. Seizure Check: Has a baseline EEG (a painless test using small stickers on the scalp to measure electrical activity in the brain) been performed to look for “hidden” seizure activity? [20]
  5. Parental Carrier Testing: Once your child’s specific mutation is found, it is crucial that both parents are tested. This confirms carrier status and is essential information for family planning and understanding the risk to future siblings [21].

Common questions in this guide

What does a cobblestone cortex mean on my child's MRI?
A cobblestone cortex means the surface of the brain looks bumpy or irregular instead of having typical smooth curves. This happens during fetal development when brain cells travel past their usual stopping point into the space around the brain.
Why do doctors check my child's CK (Creatine Kinase) levels?
Doctors check CK levels because it is an enzyme that leaks into the bloodstream when muscles are fragile or damaged. High CK levels help confirm if your child's brain malformation is part of a broader muscle condition like muscular dystrophy.
What is a Z-shaped brainstem?
A Z-shaped brainstem is a specific kinked or folded appearance seen on an MRI in some children with cobblestone lissencephaly. Because the brainstem controls basic life functions like breathing and swallowing, your neurologist will check its shape carefully.
How does cobblestone lissencephaly affect the eyes?
The genetic changes that cause cobblestone lissencephaly can also affect eye development. A pediatric ophthalmologist will look for retinal dysplasia, cataracts, and glaucoma so treatments can be started early to protect your child's vision.
Why is genetic testing important for this diagnosis?
Genetic testing, such as Whole Exome Sequencing, pinpoints the specific gene change causing the condition. This confirms the diagnosis and allows parents to be tested for carrier status, which is important for understanding risks to future children.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.The MRI report mentions a 'cobblestone' appearance. Can you point this out on the scans and explain how extensive it is in my child's brain?
  2. 2.Was a 'Z-shaped' or 'kinked' brainstem noted on the report? How does that specific shape affect my child's basic functions like breathing or swallowing?
  3. 3.My child's CK level was [insert number]. Does this level suggest a faster or slower progression of muscle weakness?
  4. 4.Has an ophthalmologist checked specifically for retinal dysplasia or signs of glaucoma? Are there treatments we should start to preserve their vision?
  5. 5.Does the genetic testing (WES) pinpoint the specific variant, and are both parents scheduled to be tested to confirm carrier status?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Cobblestone lissencephaly (Type II), clinical, and neuroimaging: A case report and literature review.

    Sharma PK, Jerosha S, Subramonian SG, et al.

    Radiology case reports 2024; (19(11)):4794-4803 doi:10.1016/j.radcr.2024.07.043.

    PMID: 39228958
  2. 2

    Cobblestone lissencephaly in the setting of congenital cytomegalovirus infection: A case report and review of the literature.

    Das S, Lachance E, Mandziuk J

    Clinical neuropathology 2026; (45(1)):26-31 doi:10.5414/NP301711.

    PMID: 41508885
  3. 3

    Prenatal diagnosis of cobblestone lissencephaly associated with Walker-Warburg syndrome based on a specific sonographic pattern.

    Lacalm A, Nadaud B, Massoud M, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2016; (47(1)):117-22 doi:10.1002/uog.15735.

    PMID: 26315758
  4. 4

    Walker-Warburg syndrome and tectocerebellar dysraphia: A novel association caused by a homozygous DAG1 mutation.

    Leibovitz Z, Mandel H, Falik-Zaccai TC, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2018; (22(3)):525-531 doi:10.1016/j.ejpn.2017.12.012.

    PMID: 29337005
  5. 5

    Comparison of brain MRI findings with language and motor function in the dystroglycanopathies.

    Brun BN, Mockler SR, Laubscher KM, et al.

    Neurology 2017; (88(7)):623-629 doi:10.1212/WNL.0000000000003609.

    PMID: 28087826
  6. 6

    Fetal Presentation of Walker-Warburg Syndrome with Compound Heterozygous POMT2 Missense Mutations.

    Zago S, Silvestri E, Arcangeli T, et al.

    Fetal and pediatric pathology 2023; (42(2)):334-341 doi:10.1080/15513815.2022.2116620.

    PMID: 36048137
  7. 7

    A Successful Treatment of Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization for Hydrocephalus in Walker-Warburg Syndrome.

    Tanaka T, Harris CJ, Barnett SS, Litofsky NS

    Case reports in neurological medicine 2016; (2016()):7627289 doi:10.1155/2016/7627289.

    PMID: 28116189
  8. 8

    Bilateral total retinal detachment at birth: a case report of Walker-Warburg syndrome.

    Hakim N, Soare C, Hakim J

    International medical case reports journal 2018; (11()):1-4 doi:10.2147/IMCRJ.S154223.

    PMID: 29386918
  9. 9

    POMT1 and POMT2 gene mutations result in 2 cases of alpha-dystroglycanopathy.

    Gan S, Yang H, Xiao T, et al.

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2021; (46(8)):915-919 doi:10.11817/j.issn.1672-7347.2021.200067.

    PMID: 34565739
  10. 10

    GDP-Mannose Pyrophosphorylase B (GMPPB)-Related Disorders.

    Chompoopong P, Milone M

    Genes 2023; (14(2)) doi:10.3390/genes14020372.

    PMID: 36833299
  11. 11

    A child of congenital muscular dystrophy-dystroglycanopathy with a novel variant in the CRPPA gene: a case report and literature review.

    Zhang S, Wu M, Li X, et al.

    Translational pediatrics 2025; (14(7)):1691-1699 doi:10.21037/tp-2025-6.

    PMID: 40800181
  12. 12

    Further evidence for POMK as candidate gene for WWS with meningoencephalocele.

    Paul L, Rupprich K, Della Marina A, et al.

    Orphanet journal of rare diseases 2020; (15(1)):242 doi:10.1186/s13023-020-01454-0.

    PMID: 32907597
  13. 13

    Optical Coherence Tomography in an Infant with Walker-Warburg Syndrome.

    Mano N, Mitsutsuji T, Yoshikawa Y, et al.

    Case reports in ophthalmology 2015; (6(2)):210-5 doi:10.1159/000435771.

    PMID: 26265907
  14. 14

    Novel mutations in B3GALNT2 gene causing α-dystroglycanopathy in Chinese patients.

    Chen XY, Song DY, Fan YB, et al.

    Chinese medical journal 2020; (134(12)):1483-1485 doi:10.1097/CM9.0000000000001283.

    PMID: 33290285
  15. 15

    Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study.

    Rosina E, Pezzani L, Apuril E, et al.

    Molecular genetics & genomic medicine 2024; (12(1)):e2316 doi:10.1002/mgg3.2316.

    PMID: 38041506
  16. 16

    Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.

    Strengman E, Barendrecht-Smouter FAS, de Voijs C, et al.

    Methods in molecular biology (Clifton, N.J.) 2019; (1908()):1-17 doi:10.1007/978-1-4939-9004-7_1.

    PMID: 30649717
  17. 17

    High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.

    Çavdarlı B, Köken ÖY, Satılmış SBA, et al.

    Annals of human genetics 2023; (87(3)):104-114 doi:10.1111/ahg.12492.

    PMID: 36575883
  18. 18

    Genetic spectrum and clinical features in a cohort of Chinese patients with autosomal recessive cerebellar ataxias.

    Cheng HL, Shao YR, Dong Y, et al.

    Translational neurodegeneration 2021; (10(1)):40 doi:10.1186/s40035-021-00264-z.

    PMID: 34663476
  19. 19

    Yield of exome sequencing in patients with developmental and epileptic encephalopathies and inconclusive targeted gene panel.

    Sedlackova L, Sterbova K, Vlckova M, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (48()):17-29 doi:10.1016/j.ejpn.2023.10.006.

    PMID: 38008000
  20. 20

    Electrographic pattern recognition: A simple tool to predict clinical outcome in children with lissencephaly.

    Jauhari P, Farmania R, Chakrabarty B, et al.

    Seizure 2020; (83()):175-180 doi:10.1016/j.seizure.2020.10.020.

    PMID: 33161247
  21. 21

    Dystroglycanopathies: About Numerous Genes Involved in Glycosylation of One Single Glycoprotein.

    Bouchet-Séraphin C, Vuillaumier-Barrot S, Seta N

    Journal of neuromuscular diseases 2015; (2(1)):27-38.

    PMID: 28198708

This guide to cobblestone lissencephaly test results is for educational purposes only and does not replace professional medical advice. Always review your child's specific MRI, lab, and genetic reports with their neurologist and care team.

Get notified when new evidence is published on Cobblestone lissencephaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.